Childhood Acute Megakaryocytic Leukemia (M7) Completed Phase 3 Trials for Valspodar (DB11869)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006363Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaTreatment